Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 98, Issue 1, Pages 15-26
Publisher
Springer Nature
Online
2017-12-18
DOI
10.1038/labinvest.2017.131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of immunocytochemistry as a morphomolecular technique
- (2016) Perry Maxwell et al. CANCER CYTOPATHOLOGY
- Digital image analysis outperforms manual biomarker assessment in breast cancer
- (2016) Gustav Stålhammar et al. MODERN PATHOLOGY
- Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics
- (2015) Kelly Elliott et al. JOURNAL OF CLINICAL PATHOLOGY
- The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
- (2014) David P Boyle et al. HISTOPATHOLOGY
- Updated UK Recommendations for HER2 assessment in breast cancer
- (2014) Emad A Rakha et al. JOURNAL OF CLINICAL PATHOLOGY
- Digital pathology and image analysis in tissue biomarker research
- (2014) Peter W. Hamilton et al. METHODS
- Molecular pathology - The value of an integrative approach
- (2014) Manuel Salto-Tellez et al. Molecular Oncology
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
- (2013) Jason R Brown et al. LABORATORY INVESTIGATION
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- (2011) Peter A Fasching et al. BMC CANCER
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Comparative validation of the SP6 antibody to Ki67 in breast cancer
- (2010) L. Zabaglo et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2 testing in the UK: further update to recommendations
- (2008) R A Walker et al. JOURNAL OF CLINICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started